Frontida BioPharm, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 7722 Dungan Road, Philadelphia, Pennsylvania (PA) 19111, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 2523348 · DUNS 079217644
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-04-02
- VAIDrug Quality Assurance2023-12-07
- VAIDrug Quality Assurance2019-07-19
- VAIDrug Quality Assurance2017-03-31
- OAIDrug Quality Assurance2015-07-17
- VAIDrug Quality Assurance2014-07-25
- VAIDrug Quality Assurance2012-01-27
- VAIDrug Quality Assurance2011-05-20
- NAIBioresearch Monitoring2009-06-30
- NAIDrug Quality Assurance2008-12-10
Drugs this plant is listed as making
2 distinct drugs across 6 products name this site in their FDA label.
- FenofibrateRhodes Pharmaceuticals LLC
- milnacipran hydrochlorideGlenmark Pharmaceuticals Inc., USA
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.